摘要
目的对比MTA和Vitapex根尖诱导成形术治疗感染型畸形中央尖的成功率。方法 98例感染型畸形中央尖患者(122颗前磨牙),依据根尖诱导药物的不同分为研究组49例(65牙)与对照组49例(57牙)。对照组予以Vitapex根尖诱导治疗,研究组予以MTA根尖诱导治疗。比较两组患者感染治疗相关指标、诱导周期以及诱导疗效。结果研究组牙周病变消失时间、咀嚼功能恢复时间、红肿消退时间均短于对照组,就诊次数少于对照组,差异具有统计学意义(P<0.05)。研究组诱导周期情况显著优于对照组,差异具有统计学意义(P<0.05)。研究组组诱导成功率为95.38%,显著高于对照组的80.70%,差异具有统计学意义(P<0.05)。结论予以感染型畸形中央尖患者MTA根尖诱导治疗可缩短感染治疗时间,并提高诱导成功率,值得推广。
Objective To compare success rate between MTA and Vitapex apexification in the treatment of infectious central cusp deformity. Methods A total of 98 patients with infectious central cusp deformity（122 premolar teeth） were divided by different apical induction drugs into research group with 49 cases（65 teeth） and control group with 49 cases（57 teeth）. The control group received Vitapex apexification for treatment, and the research group received MTA apexification for treatment. Comparison was made on related indexes in infection treatment, induction duration and induction effect between the two groups. Results The research group had all shorter periodontal lesion disappearance time, masticatory function recovery time, and swelling relief time than the control group, and it had fewer treatment times than the control group. Their difference had statistical significance（P〈0.05）. The research group had obviously better induction duration status than the control group, and their difference had statistical significance（P〈0.05）. The research group had much higher induction success rate as 95.38% than 80.70% in the control group, and their difference had statistical significance（P〈0.05）. Conclusion Implement of MTA apexification for infectious central cusp deformity patients can shorten infection treatment time and improve induction success rate, and this method is worth promoting.
出处
《中国实用医药》
2017年第8期55-57,共3页
China Practical Medicine
